| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.24 | 6e-10 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-07 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-06 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.22 | 4e-05 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.16 | 7e-05 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |